ArticleProceedings of the National Academy of Sciences of the United States of America2023

Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.

Danielle H Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.